Overview Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies Status: Completed Trial end date: 2015-12-01 Target enrollment: Participant gender: Summary Determine the safety and tolerability of POL6326 when used as a single mobilization agent. Phase: Phase 1/Phase 2 Details Lead Sponsor: Polyphor Ltd.